NCT00058370View on ClinicalTrials.gov

Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

cisplatin

DRUG

lomustine

DRUG

vincristine sulfate

PROCEDURE

adjuvant therapy

RADIATION

iodine I 131 monoclonal antibody 3F8

RADIATION

radiation therapy

Trial Locations (2)

10032

Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00058370 - Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma | Biotech Hunter | Biotech Hunter